Full Text Journal Articles by
Author Suanna S Bruinooge

Advertisement

Find full text journal articles






Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors.

Kathryn F Mileham, Caroline Schenkel, Meredith K Chuk, Andrea Buchmeier, Raymond P Perez, Patricia Hurley, Laura A Levit, Elizabeth Garrett-Mayer, Courtney Davis, Suanna S Bruinooge, Julie Vose,

PURPOSE:Investigators often send reports to sponsors that incorrectly categorize adverse event (AE)s as serious or attribute AEs to investigational drugs. Such errors can contribute to high volumes of uninformative investigational new drug safety reports that sponsors submit to the US Food and Drug Administration and participating investigators, which strain resources ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2019, :JOP1900366]

Cited: 0 times

View full text PDF listing >>



State of Cancer Care in America: Reflections on an Inaugural Year.

Blase N Polite, Jerome E Seid, Morganna Freeman, Laura A Levit, M Kelsey Kirkwood, Caroline Schenkel, Suanna S Bruinooge, Richard L Schilsky,

J Oncol Pract (Journal of oncology practice)
[2019, 15(4):163-165]

Cited: 0 times

View full text PDF listing >>



Advertisement

Understanding the role of advanced practice providers in oncology in the United States.

Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, Amy Hanley, Caroline Schenkel, Elizabeth Garrett-Mayer, Eric Tetzlaff, Margaret Rosenzweig, Heather Hylton, Shannon N Westin, Noël Smith, Conor Lynch, Michael P Kosty, Stephanie F Williams,

PURPOSE:Advanced practice providers (APPs, which include NPs and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all APPs in oncology and, second, to understand personal and practice characteristics (including compensation) of those APPs. METHODS:We identified APPs who practice oncology from membership and claims ... Read more >>

JAAPA (JAAPA : official journal of the American Academy of Physician Assistants)
[2018, 31(12):1-12]

Cited: 0 times

View full text PDF listing >>



Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, Amy Hanley, Caroline Schenkel, Elizabeth Garrett-Mayer, Eric Tetzlaff, Margaret Rosenzweig, Heather Hylton, Shannon N Westin, Noël Smith, Conor Lynch, Michael P Kosty, Stephanie F Williams,

Purpose: Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to understand personal and practice characteristics (including compensation) of those APPs. Methods: We identified APPs who practice oncology from ... Read more >>

J Adv Pract Oncol (Journal of the advanced practitioner in oncology)
[2018, 9(6):585-598]

Cited: 0 times

View full text PDF listing >>



Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, Amy Hanley, Caroline Schenkel, Elizabeth Garrett-Mayer, Eric Tetzlaff, Margaret Rosenzweig, Heather Hylton, Shannon N Westin, Noël Smith, Conor Lynch, Michael P Kosty, Stephanie F Williams,

PURPOSE:Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to understand personal and practice characteristics (including compensation) of those APPs. METHODS:We identified APPs who practice oncology from membership and ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2018, 14(9):e518-e532]

Cited: 0 times

View full text PDF listing >>



A New Look at the State of Cancer Care in America.

Blase N Polite, Jerome E Seid, Laura A Levit, M Kelsey Kirkwood, Caroline Schenkel, Suanna S Bruinooge, Stephen S Grubbs, Deborah Y Kamin, Richard L Schilsky,

J Oncol Pract (Journal of oncology practice)
[2018, 14(7):397-399]

Cited: 1 time

View full text PDF listing >>



Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Pam K Mangat, Susan Halabi, Suanna S Bruinooge, Elizabeth Garrett-Mayer, Ajjai Alva, Katherine A Janeway, Philip J Stella, Emile Voest, Kathleen J Yost, Jane Perlmutter, Navin Pinto, Edward S Kim, Richard L Schilsky,

Purpose:Case reports and small prospective trials suggest that administering targeted therapies to patients with advanced cancer and an identified genomic target may be associated with clinical benefit. The TAPUR Study, a phase II, prospective, non-randomized, multi-basket, pragmatic clinical trial aims to identify signals of drug activity when Food and Drug ... Read more >>

JCO Precis Oncol (JCO precision oncology)
[2018, 2018:]

Cited: 2 times

View full text PDF listing >>



The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

M Kelsey Kirkwood, Amy Hanley, Suanna S Bruinooge, Elizabeth Garrett-Mayer, Laura A Levit, Caroline Schenkel, Jerome E Seid, Blase N Polite, Richard L Schilsky,

PURPOSE:To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey. PARTICIPANTS AND METHODS:ASCO used Medicare Physician Compare data to characterize oncology practices in the United States. Practice size, number of care sites, and geographic distribution were determined. ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2018, 14(7):e412-e420]

Cited: 8 times

View full text PDF listing >>



Impact on Oncology Practices of Including Drug Costs in Bundled Payments.

Jeffery C Ward, Laura A Levit, Ray D Page, John E Hennessy, John V Cox, Deborah Y Kamin, Suanna S Bruinooge, Ya-Chen Tina Shih, Blase N Polite,

INTRODUCTION:This analysis evaluates the impact of bundling drug costs into a hypothetic bundled payment. METHODS:An economic model was created for patient vignettes from: advanced-stage III colon cancer and metastatic non-small-cell lung cancer. First quarter 2016 Medicare reimbursement rates were used to calculate the average fee-for-service (FFS) reimbursement for these vignettes. ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2018, 14(5):e259-e268]

Cited: 3 times

View full text PDF listing >>



Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J Lazar, Neal Lindeman, Christina M Lockwood, Alex J Rai, Richard L Schilsky, Apostolia M Tsimberidou, Patricia Vasalos, Brooke L Billman, Thomas K Oliver, Suanna S Bruinooge, Daniel F Hayes, Nicholas C Turner,

Purpose Clinical use of analytical tests to assess genomic variants in circulating tumor DNA (ctDNA) is increasing. This joint review from ASCO and the College of American Pathologists summarizes current information about clinical ctDNA assays and provides a framework for future research. Methods An Expert Panel conducted a literature review ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2018, 36(16):1631-1641]

Cited: 56 times

View full text PDF listing >>



Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J Lazar, Neal Lindeman, Christina M Lockwood, Alex J Rai, Richard L Schilsky, Apostolia M Tsimberidou, Patricia Vasalos, Brooke L Billman, Thomas K Oliver, Suanna S Bruinooge, Daniel F Hayes, Nicholas C Turner,

PURPOSE.—:Clinical use of analytical tests to assess genomic variants in circulating tumor DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology and the College of American Pathologists summarizes current information about clinical ctDNA assays and provides a framework for future research. METHODS.—:An Expert Panel conducted ... Read more >>

Arch. Pathol. Lab. Med. (Archives of pathology & laboratory medicine)
[2018, 142(10):1242-1253]

Cited: 8 times

View full text PDF listing >>



Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Edward S Kim, Suanna S Bruinooge, Samantha Roberts, Gwynn Ison, Nancy U Lin, Lia Gore, Thomas S Uldrick, Stuart M Lichtman, Nancy Roach, Julia A Beaver, Rajeshwari Sridhara, Paul J Hesketh, Andrea M Denicoff, Elizabeth Garrett-Mayer, Eric Rubin, Pratik Multani, Tatiana M Prowell, Caroline Schenkel, Marina Kozak, Jeff Allen, Ellen Sigal, Richard L Schilsky,

Purpose The primary purposes of eligibility criteria are to protect the safety of trial participants and define the trial population. Excessive or overly restrictive eligibility criteria can slow trial accrual, jeopardize the generalizability of results, and limit understanding of the intervention's benefit-risk profile. Methods ASCO, Friends of Cancer Research, and ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2017, 35(33):3737-3744]

Cited: 31 times

View full text PDF listing >>



Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.

Stuart M Lichtman, R Donald Harvey, Marie-Anne Damiette Smit, Atiqur Rahman, Michael A Thompson, Nancy Roach, Caroline Schenkel, Suanna S Bruinooge, Patricia Cortazar, Dana Walker, Louis Fehrenbacher,

Purpose Patients with organ dysfunction, prior or concurrent malignancies, and comorbidities are often excluded from clinical trials. Excluding patients on the basis of these factors results in clinical trial participants who are healthier and younger than the overall population of patients with cancer. Methods ASCO and Friends of Cancer Research ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2017, 35(33):3753-3759]

Cited: 12 times

View full text PDF listing >>



Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.

Christine B Mackay, Kaitlyn R Antonelli, Suanna S Bruinooge, Jarron M Saint Onge, Shellie D Ellis,

The Affordable Care Act (ACA) includes a mandate requiring most private health insurers to cover routine patient care costs for cancer clinical trial participation; however, the impact of this provision on cancer centers' efforts to accrue patients to clinical trials has not been well described.First, members of cancer research centers ... Read more >>

Cancer (Cancer)
[2017, 123(15):2893-2900]

Cited: 1 time

View full text PDF listing >>



Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.

Jeffrey S Weber, Laura A Levit, Peter C Adamson, Suanna S Bruinooge, Howard A Burris, Michael A Carducci, Adam P Dicker, Mithat Gönen, Stephen M Keefe, Michael A Postow, Michael A Thompson, David M Waterhouse, Susan L Weiner, Lynn M Schuchter,

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2017, 35(2):139-140]

Cited: 6 times

View full text PDF listing >>



National Cancer Institute-American Society of Clinical Oncology Teams in Cancer Care Project.

Michael P Kosty, Amy Hanley, Veronica Chollette, Suanna S Bruinooge, Steven H Taplin,

J Oncol Pract (Journal of oncology practice)
[2016, 12(11):955-958]

Cited: 4 times

View full text PDF listing >>



Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.

Julie M Vose, Laura A Levit, Patricia Hurley, Carrie Lee, Michael A Thompson, Teresa Stewart, Janie Hofacker, Suanna S Bruinooge, Daniel F Hayes,

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2016, 34(31):3796-3802]

Cited: 6 times

View full text PDF listing >>



Reply to N. Lowy et al and to J. Dhanda et al.

Arti Hurria, Laura A Levit, William Dale, Supriya G Mohile, Hyman B Muss, Louis Fehrenbacher, Allison Magnuson, Stuart M Lichtman, Suanna S Bruinooge, Enrique Soto-Perez-de-Celis, William P Tew, Michael A Postow, Harvey J Cohen,

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2016, 34(14):1708-1709]

Cited: 0 times

View full text PDF listing >>



Reply to H.G. Muntz et al.

M Kelsey Kirkwood, Suanna S Bruinooge, Amy Hanley, Jamie H Von Roenn, Deborah Y Kamin,

J Oncol Pract (Journal of oncology practice)
[2015, 11(5):428]

Cited: 0 times

View full text PDF listing >>



Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

Jennifer A Ligibel, Catherine M Alfano, Dawn Hershman, Rachel M Ballard, Suanna S Bruinooge, Kerry S Courneya, Elvan C Daniels, Wendy Demark-Wahnefried, Elizabeth S Frank, Pamela J Goodwin, Melinda L Irwin, Laura A Levit, Worta McCaskill-Stevens, Lori M Minasian, Mark A O'Rourke, John P Pierce, Kevin D Stein, Cynthia A Thomson, Clifford A Hudis,

Observational evidence has established a relationship between obesity and cancer risk and outcomes. Interventional studies have demonstrated the feasibility and benefits of lifestyle change after cancer diagnosis, and guidelines recommend weight management and regular physical activity in cancer survivors; however, lifestyle interventions are not a routine part of cancer care. ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2015, 33(33):3961-3967]

Cited: 21 times

View full text PDF listing >>



Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.

Chun Chieh Lin, Suanna S Bruinooge, M Kelsey Kirkwood, Christine Olsen, Ahmedin Jemal, Dean Bajorin, Sharon H Giordano, Michael Goldstein, B Ashleigh Guadagnolo, Michael Kosty, Shane Hopkins, James B Yu, Anna Arnone, Amy Hanley, Stephanie Stevens, Dawn L Hershman,

Geographic access to care may be associated with receipt of chemotherapy but has not been fully examined. This study sought to evaluate the association between density of oncologists and travel distance and receipt of adjuvant chemotherapy for colon cancer within 90 days of colectomy.Patients in the National Cancer Data Base ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2015, 33(28):3177-3185]

Cited: 36 times

View full text PDF listing >>



Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.

Arti Hurria, Laura A Levit, William Dale, Supriya G Mohile, Hyman B Muss, Louis Fehrenbacher, Allison Magnuson, Stuart M Lichtman, Suanna S Bruinooge, Enrique Soto-Perez-de-Celis, William P Tew, Michael A Postow, Harvey J Cohen, ,

The American Society of Clinical Oncology (ASCO) convened a subcommittee to develop recommendations on improving the evidence base for treating older adults with cancer in response to a critical need identified by the Institute of Medicine. Older adults experience the majority of cancer diagnoses and deaths and make up the ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2015, 33(32):3826-3833]

Cited: 63 times

View full text PDF listing >>



Modernizing Eligibility Criteria for Molecularly Driven Trials.

Edward S Kim, David Bernstein, Susan G Hilsenbeck, Christine H Chung, Adam P Dicker, Jennifer L Ersek, Steven Stein, Fadlo R Khuri, Earle Burgess, Kelly Hunt, Percy Ivy, Suanna S Bruinooge, Neal Meropol, Richard L Schilsky,

As more clinical trials of molecularly targeted agents evolve, the number of eligibility criteria seems to be increasing. The importance and utility of eligibility criteria must be considered in the context of the fundamental goal of a clinical trial: to understand the risks and benefits of a treatment in the ... Read more >>

J. Clin. Oncol. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2015, 33(25):2815-2820]

Cited: 31 times

View full text PDF listing >>



Teams and teamwork during a cancer diagnosis: interdependency within and between teams.

Stephen H Taplin, Sallie Weaver, Veronica Chollette, Lawrence B Marks, Andrew Jacobs, Gordon Schiff, Carrie T Stricker, Suanna S Bruinooge, Eduardo Salas,

This article discusses the care process among three groups (primary care, radiology, and surgery) aiding a 57-year-old woman during her screening mammography and diagnosis of breast cancer. This is the first in a series of articles exploring principles and topics relevant to teams guiding clinicians involved in cancer care. The ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2015, 11(3):231-238]

Cited: 25 times

View full text PDF listing >>



Reviewing cancer care team effectiveness.

Stephen H Taplin, Sallie Weaver, Eduardo Salas, Veronica Chollette, Heather M Edwards, Suanna S Bruinooge, Michael P Kosty,

PURPOSE:The management of cancer varies across its type, stage, and natural history. This necessitates involvement of a variety of individuals and groups across a number of provider types. Evidence from other fields suggests that a team-based approach helps organize and optimize tasks that involve individuals and groups, but team effectiveness ... Read more >>

J Oncol Pract (Journal of oncology practice)
[2015, 11(3):239-246]

Cited: 34 times

View full text PDF listing >>



Advertisement

Disclaimer
1.6726 s